Connect with the Global Synthetic Biology Community

The focus of this year’s conference is to connect the global synthetic biology community by fostering the dialogue between entrepreneurs, business executives, tech practitioners, technology scouts, academics, and investors. Join us for insightful discussions on: advancements in metabolic engineering, designer biomaterials, engineering biology for consumer products, engineering environmental sustainability in the circular economy, hardware to make biology easier to engineer, public perception on engineering biology, and if synthetic biology will be the key to our future health. Become a member today and gain access to event discounts.

SynBioBeta London 2017

Date & Location:

April 4, 2017 - April 6, 2017
 

Sherfield Building, Imperial College London
Venue Information

Register Now
Subscribe for Alerts

Event Hosts

Silver Sponsors

Bronze Sponsors

Networking Cruise on the River Thames – April 6th, Thursday

This event will give you ample time to connect while you enjoy lunch aboard the M.V. Harmony, and take in the impressive sights of London.

Register Now


Featured Speakers

Janet Bainbridge

Janet Bainbridge
UK Trade & Investment

Thomas P. Bostick

Thomas P. Bostick
Intrexon

Speakers

Tahel Altman

Tahel Altman
SynVaccine

Ryan Bethencourt

Ryan Bethencourt
SOSventures

Andy Boyce

Andy Boyce
BrisSynBio

Tessa Callaghan

Tessa Callaghan
AlgiKnit

Ryan Cawood

Ryan Cawood
Oxford Genetics

Joanne Channon

Joanne Channon
Cambridge Consultants

Natsai Audrey Chieza

Natsai Audrey Chieza
Faber Futures

Núria Conde Pueyo

Núria Conde Pueyo
Moirai Biodesign

Davide De Lucrezia

Davide De Lucrezia
Explora Biotech

Joanna Dupont Inglis

Joanna Dupont Inglis
EuropaBio

Kristin Ellis

Kristin Ellis
Opentrons

Tim Fell

Tim Fell
Synthace

Paul Freemont

Paul Freemont
SynbiCITE

Lina Gasiūnaitė

Lina Gasiūnaitė
Biotangents

Sabrina German

Sabrina German
Primordial Genetics

Christine Gould

Christine Gould
Syngenta

Peter Haslett

Peter Haslett
Realeyes

Klaus Hentrich

Klaus Hentrich
TTP Labtech

Stephan Herrera

Stephan Herrera
Evolva

Kevin Holden

Kevin Holden
Synthego

Richard Kitney

Richard Kitney
SynbiCITE

Emily Leproust

Emily Leproust
Twist Bioscience

Teng Li

Teng Li
BluePHA

Amy Liao

Amy Liao
GENEWIZ

Yvonne Linney

Yvonne Linney
Transcriptic

Meagan Lizarazo

Meagan Lizarazo
iGEM Foundation

Dirk Loeffert

Dirk Loeffert
BioMillenia

Irina Makkaveeva

Irina Makkaveeva
protocols.io

Philippe Marlière

Philippe Marlière
Global Bioenergies

Louis Metzger

Louis Metzger
Novartis

Giles Ochs

Giles Ochs
Prospect Bio

Petra Oyston

Petra Oyston
DSTL

Jim Philp

Jim Philp
OECD

Nimesh Pinnamaneni

Nimesh Pinnamaneni
Helixworks

Ben Reeve

Ben Reeve
CustoMem

Sandra Rey

Sandra Rey
Glowee

Michael Roberts

Michael Roberts
Synpromics

Isabel Rocha

Isabel Rocha
SilicoLife

Tanya Sahanga

Tanya Sahanga
adidas

John Sgouros

John Sgouros
BioMax

Morten Sommer

Morten Sommer
Biosyntia

Elsa Sotiriadis

Elsa Sotiriadis
SOSV

Per Tomani

Per Tomani
LignoCity

Simon Trancart

Simon Trancart
Heurisko

Mandy Vink

Mandy Vink
Codexis

Sean Ward

Sean Ward
Synthace

Renee Wegrzyn

Renee Wegrzyn
DARPA

Bethan Wolfenden

Bethan Wolfenden
Bento Bio

Aleksandra Wlodek

Aleksandra Wlodek
Isomerase Therapeutics

Orr Yarkoni

Orr Yarkoni
Colorifix

Thomas Ybert

Thomas Ybert
DNA Script

Paul Young

Paul Young
MilisBio

Day 1 – April 4th, Tuesday

Come listen as we showcase industry-leading companies as they update the audience on their latest developments and news, making this session perfect for gaining a rapid-fire overview of the current landscape. Which cities are at the top of the list to watch in the coming year?

Speakers: Andy Boyce, BrisSynBio
Birgit Wiltschi, ACIB
Michel Manach, Toulouse White Biotechnology
Nethaji Gallage, University of Copenhagen
Isabel Rocha, SilicoLife
Ping Yang, Synbio Technologies
Meagan Lizarazo, iGEM

Drew Endy, Stanford University
Christine Gould, Syngenta
General Thomas Bostick, Intrexon
Synthetic biology offers the potential to revolutionize many industries, but the one at the front both in terms of opportunity and ability to do good is the production of bio-based pharmaceuticals and cell therapies. Come learn how synthetic biology is helping to produce the latest pharmaceuticals and is improving lives through unique healthcare products.

Moderator: Nuria Conde, Moirai Biodesign
Speakers: Louis Metzger, Novartis
Volker Morath, TUM
Tahel Altman, SynVaccine
Aleksandra Wlodek, Isomerase Therapeutics
John Sgouros, Biomax
Ryan Cawood, Oxford Genetics

Our industry-leading speakers update the audience on their latest developments and news. You’ll be able to listen and engage in these rapid-fire overviews of companies offering novel genetic engineering techniques.​

Moderator: Sarah Lau, Kilburn & Strode
Speakers: Emily Leproust, Twist Bioscience
Thomas Ybert, DNA Script
Klaus Hentrich, TTP Labtech
Axel Trefzer, Thermo Fisher Scientific
Paul Young, MilisBio
Mandy Vink, Codexis
Lina Gasiūnaitė, Biotangents
Yvonne Linney, Transcriptic

Lord David Prior, Department for Business, Energy and Industrial Strategy
Tim Fell, Synthace
Hermann Hauser, Amadeus Capital Partners

Day 2 – April 5th, Wednesday

Joyce Tait, Innogen Institute
Mark Lynas, Environmental Writer
The synthetic biology field is rapidly advancing, policy makers and thought leaders are being called upon to make decisions and provide guidance to the public grappling with potential implications.  Recognizing the public concern about science and technology often relates to political and ethical factors.  During this panel, hear from panelists who are addressing questions and concerns that are being raised by these developments and discussing the strategies to effectively communicate with the public.

Moderator: Stephan Herrera,  Evolva
Speakers: Elsa Sotiriadis, SOSV
Joanna Dupont Inglis, EuropaBio
Peter Haslett, Realeyes

What applications are out there to modify microbes to digest byproducts that are harmful to our environment? How can we manipulate the environment with engineered microbes to solve larger problems? Our community is tackling waste water management, air pollution control, waste disposal, radiation protection, environmental sustainability and industrial hygiene.  Circular economies are part of the ongoing narrative on industrial sustainability covering resource productivity, reduced energy and water use, food security and increasing the efficiency of land use.

Moderator: Amy Tayler, Knowledge Transfer Network
Speakers: Per Tomani, LignoCity
Orr Yarkoni, Colorifix
Ben Reeve, CustoMem
Sandra Rey, Glowee

Our ability to read, write, and rewrite DNA makes it possible to engineer all sorts of organisms ranging from microbes to plants to animals. Biomaterials design is a highway towards the discovery and realization of tailored polymeric materials to satisfy the specific requirements of many diverse applications. Learn about those making tools for designing biology along with insights relating to the creation of novel biomaterials from renewable and sustainable sources.

Moderator: Liz Fletcher, UK Centre for Mammalian Synthetic Biology
Speakers: Petra Oyston, DSTL
Natsai Chieza, Faber Futures
Li Teng, BluePHA
Joanne Channon, Cambridge Consultants
Tessa Callaghan, AlgiKnit

Recently, a number of companies have made advancements in engineering microbes for new applications. In this session, we will hear from companies engineering biology to make consumer products from clothing and textiles to personal care products and more. Explore the bio strategy of companies moving to more sustainable methods of manufacturing and learn about the latest entries into consumer markets.

Moderator: Tanya Sahanga, adidas
Speakers: Nimesh Pinnamaneni, Helixworks
Dirk Loeffert, BioMillenia
Ryan Bethencourt, IndieBio
Dana Heldt, CHAIN Biotechnology

Gene editing has exploded and rarely does a talk go by without some sort of CRISPR modification being mentioned. Our capabilities are allowing us to better engineer biology in order to create improved chemicals, drugs, foods, fuels and more via sustainable processes – something that was once thought to be impossible. In this session the practitioners of gene editing and metabolic engineering will dive into their latest discoveries and processes as they strive to make biology easier to engineer.

Moderator: Amy Liao, GENEWIZ
Speakers: Simon Trancart, Heurisko
Michael Roberts, Synpromics
Morten Sommer, Biosyntia
Sabrina German, Primordial Genetics
Dave Wernick, Weizmann Institute of Science
Kevin Holden, Synthego

With our growing ability to collect increasingly large amounts of data from biological systems, comes the obligation to reliably store, analyze and manipulate this information. Machine learning offers the potential for automated data analysis and creation of hypothesis. These technologies are making our tools more autonomous and allowing them to better communicate with each other in order to complete protocols and accomplish experiments as designed. What changes will these technologies bring and how will they affect synthetic biology? In this session we have assembled industry leading experts in big data and machine learning to explain the paramount roles of these technologies.

Moderator: Renee Wegrzyn, DARPA
Speakers: Davide De Lucrezia, Explora Biotech
Irina Makkaveeva, Protocols.io
Bethan Wolfenden, Bento Bio
Giles Ochs, Prospect Bio
Sean Ward, Synthace
Kristin Ellis, Opentrons

Moderator: Paul Freemont, SynbiCITE
Speakers: Jim Philp, OECD
Richard Kitney, SynbiCITE
Janet Bainbridge, UK Trade & Investment

Day 3 – April 6th, Thursday

Advisory Committee

John Cumbers

John Cumbers
SynBioBeta

Paul Freemont

Paul Freemont
SynbiCITE

Sarah Haywood

Sarah Haywood
MedCity

Richard Kitney

Richard Kitney
SynbiCITE

Amy Liao

Amy Liao
GENEWIZ

Yvonne Linney

Yvonne Linney
Transcriptic

John Sgouros

John Sgouros
Biomax

Kate Wildauer

Kate Wildauer
SynBioBeta

Testimonials

Rob Carlson

“A valuable venue for entrepreneurs and investors to meet, share ideas, and start collaborations. The event’s biggest problem will be managing the waiting list to get in.”

Rob Carlson, Principal at Biodesic, Author “Biology is Technology”

Dan Widmaier

“SynBioBeta is uniquely focused on startups and entrepreneurs trying to change the world and the challenges we face to get to market. As a startup founder, SynBioBeta is the most pertinent conference to the issues I deal with on a daily basis.”

Dan Widmaier, CEO of Bolt Threads

Lindy Fishburne

“A must-do meeting for anyone working in, or investing in synthetic biology companies.”

Lindy Fishburne, Executive Director of Breakout Labs

Networking App

The SynBioBeta Meeting App one-to-one meeting software enables you to book meetings with other delegates online ahead of the event, and manage your schedule. If you are registered for the conference, you will need to register to edit your details (including your company profile), browse company entries and pre-request meetings. If you need assistance please check our FAQ guide.

Contact us

Sponsorship & Exhibit Opportunities

Our sponsorship and exhibitor packages are flexible and provide lots of opportunities for you to connect with the community.
Contact us

Exhibitors

Partners

iGEM

iGEM Community receives 30% off registration. Get the code.

Who’s Coming?

Abolis Biotechnologies
adidas AG
Ajinomoto Co., Inc.
Algenuity, a division of Spicer Consulting
AlgiKnit
Amadeus Capital Partners
AMSilk GmbH
Analytik Jena AG
Ananas Anam
Anterra Capital
Austrian Centre of Industrial Biotechnology
BBSRC
BEIS
Bento Bio
BGene Genetics
Bio-Based World News
Biolegio BV
Biomax Informatics AG
BIOMILLENIA
Biosyntia
Biotangents
Bluepha Co., Ltd.
Booz Allen Hamilton / DARPA
BrisSynBio
Brunel University London
Cambridge Consultants
CEA / Genomics Institute
Centre for Synthetic and Systems Biology
CHAIN Biotechnology Ltd
Codexis, Inc.
Colorifix
Conagen Inc
Copenhagen Capacity
Corbion
Cornell Alliance for Science
CPI
CSIRO
CustoMem
CyBio Northern Europe Ltd
DARPA
Demethra srl
Department of Homeland Security
digi.bio
DIT
DNA Script
Drug Discovery Today
DSTL
Edinburgh Genome Foundry
Emerald Technology Ventures
Epiphany Capital
Esco Ventures
ETH Zurich
Evonetix Ltd
EXPLORA BIOTECH
Faber Futures
FGen GmbH

Future of Humanity Institute
GENEWIZ
GenScript
Gilson UK
GIP GENOPOLE
Glowee
Green Biologics
Helixworks Technologies
Hermes Sellier
Heurisko
Hitachi High-Technologies Corporation
IBioIC
iGEM
iGlobe Partners
Illumina Ventures
Imperial College London
Imperial Innovations
Imperial/GSK
Imperial/Royal College of Art
IndieBio/SOSV
Innogen Institute, University of Edinburgh
INRA TWB
Intrexon Corporation
Isomerase Therapeutics Ltd
Jon Rees Associates
KAIST
KAUST
Kilburn & Strode LLP
Korea Advanced Institute of Science and Technology
LabAssistant
Labcyte, Inc.
LabGenius
Labiotech.eu
Lonza Biologics
MALAYSIAN BIOTECHCORP INTERNATIONAL
MEIOGENIX
Microsoft
MIT
Mitsui & Co. Deutschland GmbH
MoiRai Biodesign SL
National University of Ireland Galway
Nature Publishing Group
Nature Research
NIBS
Novartis
Nuclera Nucleics Ltd.
OECD
Office of Naval Research Global
Opentrons Labworks Inc
Oxford Genetics Ltd
Oxford University Hospitals
Oxitec Ltd
Primordial Genetics
Prospect Bio
protocols.io
Rainbow Seed Fund

Realeyes
RebelBio
Reuters
RISE Bioeconomy
Rothamsted Research
SC Ventures
Sciad Communications
Scientific Institute for Public Health
SGI-DNA
SilicoLife, Ltd
Singer Instruments
So Toulouse-Invest in Toulouse
SOSventures & RebelBio
Sphere Fluidics
Studio Alexandra Daisy Ginsberg
SynbiCITE
SynBio CDT – University of Bristol
Synbio Technologies
SynBioBeat
SYNBIOCHEM
Synpromics Ltd
Synthace Ltd
Synthego
Synthetic Biology Research Centre, The University of Nottingham
Synthetic Biology Special Interest Group
SYNVACCINE
Tallinn University of Technology
Technical University of Munich (TUM)
The Chemical Engineer magazine
The Economist
The Royal Society
The University of Manchester
Thermo Fisher Scientific
Thermo Fisher Scientific Geneart GmbH
Touchlight Genetics
Transcriptic inc
TTP Labtech
Twist Bioscience
UK SynBio Leadership Council
University College Cork
University College London
University of Birmingham
University of Bristol
University of Cambridge
University of Copenhagen
University of Edinburgh
University of Kent
University of Manchester
University of Oxford
University of Warwick
University of York
US EMBASSY LONDON
VIB
Visbion Ltd
Weizmann Institute of Science
Ziba Design Innovation

Breakdown of SynBioBeta London 2016 Attendees

Meet Top Level Executives and Get Down to Business

SynBioBeta draws a strong crowd of Founders, Executives, Directors, and Managers across a number of industry markets. With our partnering meeting tools and dedicated meeting space at the event you have ample chances to connect.

Attendees by Job Level

SynBioBeta London 2017 Attendees by Job Level

Meet Top Level Executives and Get Down to Business

SynBioBeta draws a strong crowd of Founders, Executives, Directors, and Managers across a number of industry markets. With our partnering meeting tools and dedicated meeting space at the event you have ample chances to connect.

Attendees by Job Level

SynBioBeta London 2017 Attendees by Job Level

A Strong Focus on Industry while Connecting Academia

Industry companies and startups make up for almost 50% of attendance, while another 38% is represented by academia. This mix helps provide attendees with the opportunity to connect and discuss the latest science and business.

Attendees by Type

SynBioBeta London 2017 Attendees by Type

Who Should Attend?

Industry and Startups
Get critical opportunities to network, exhibit, and make the connections that you and your company need to grow.

Investors and Angels
Keep a finger on the pulse of technological development, and meet founders and investors as you hunt for your next unicorn.

Technology Scouts
Learn who the leading lights are in each segment, identify value-adding technologies, and lay the groundwork for further deals.

Academics
Gain access to professionals ranging from eager potential cofounders to sagely experienced entrepreneurs and well-connected investors.

Students and Biohackers
Get yourself involved by meeting industry leaders and laying the groundwork for your community connections.

Pioneers and Thought-leaders
Meet the people leading the field or coming to the conference from other industry leadership positions.

Policy makers
Meet those creating vibrant innovation ecosystems in their global and local regions.

Tech Practitioners
Hear about the latest technology, spot the upcoming trends, and meet the key people busily building the future.

Cancellation Policy:
Registered attendees can transfer their ticket to another person, another SynBioBeta event, or cancel up to 30 days before the event for a $50 change fee. No refunds will be issued less than 30 days before the event. Please contact kristen.bassill@synbiobeta.com for more information.

Accommodation

The recommended hotel accommodation for SynBioBeta London 2017 is: DoubleTree by Hilton Hotel London – Hyde Park 150 Bayswater Road, London, W2 4RT, United Kingdom. All rooms are on a first come first serve basis and are filling up quickly. To reserve a room and get the discounted rate, you must fill out the booking form and email it to: Dominika Klimunt (groups@doubletreelondonhydepark.co.uk) along with the Booking Code: GSYNC.

Double rooms for sole: £125.00 per room per night / Double use supplement £10.00 per night / Doubletree Cookies, Full English Breakfast, VAT and Wi-Fi internet access included per room per night. If you have any other questions please contact Jeff Wagenmann, Director of Events & Facilities at SynBioBeta.